Cancer Genetics & Hereditary Risk

Articles in this category examine hereditary cancer risk assessment, germline genetic testing, BRCA mutations, Lynch syndrome, and other inherited cancer predisposition syndromes.
The aim is to clarify when genetic testing is clinically appropriate, how results influence treatment planning, and how family-based risk stratification can inform screening and prevention strategies.

When Should Patients Undergo Genetic Testing for Cancer Risk?

Genetic testing for cancer risk should be considered when personal or family history suggests a hereditary cancer syndrome. This includes […]

Cancer Genetics & Hereditary Risk

When and Why Genetic Testing Matters in Cancer Treatment and Prevention

Dr Raman Narang / February 25, 2026 / Cancer Genetics & Hereditary Risk

Genetic testing in cancer evaluates inherited (germline) mutations that may influence both treatment decisions and long-term risk assessment. It helps